Biomarkers of HIV related central nervous system disease

International Review of Psychiatry

Volumn 20, Issue 1, 2008, Pages 73-88

  Brew, Bruce James ^a   Letendre, Scott Lee ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; ARACHIDONIC ACID; BETA 2 MICROGLOBULIN; CD4 ANTIBODY; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN; PROTEIN S 100; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UROKINASE RECEPTOR; VIRUS DNA;

ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CYTOKINE PRODUCTION; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROGLIA; NEUROFILAMENT; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

BIOLOGICAL MARKERS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HIV INFECTIONS; HUMANS;

EID: 38849193303     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260701878082     Document Type: Review

References (146)

1. Abdulle, S., Hagberg, L., & Gisslen, M. (2005). Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Medicine, 6, 164-169.
2. Abdulle, S., Hagberg, L., Svennerholm, B., Fuchs, D., & Gisslen, M. (2002). Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. AIDS, 16, 2145-2149.
3. Abdulle, S., Mellgren, A., Brew, B.J., Cinque, P., Hagberg, L., Price, R.W. et al. (2007). CSF neurofilament protein (NFL)-A marker of active HIV-related neurodegeneration. Journal of Neurology, 254(8), 1026-1032.
4. Achim, C.L., Heyes, M.P., & Wiley, C.A. (1993). Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. Journal of Clinical Investigation, 91, 2769-2775.
5. Albrecht, D., Garcia, L., Cartier, L., Kettlun, A.M., Vergara, C., Collados, L. et al. (2006). Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease. AIDS Research Hum Retroviruses, 22, 248-254.
6. Andersson, L.M., Hagberg, L., Fuchs, D., Svennerholm, B., & Gisslen, M. (2001). Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals - Correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. Journal of Neurovirology, 7, 542-547.
7. Andreasen, N., Sjogren, M., & Blennow, K. (2003). CSF markers for Alzheimer's disease: Total tau, phospho-tau and Abeta42. World Journal of Biol Psychiatry, 4, 147-155.
8. Armitage, R.J. (1994). Tumor necrosis factor receptor superfamily members and their ligands. Current Opinion Immunol, 6, 407-413.
9. Avison, M.J., Nath, A., Greene-Avison, R., Schmitt, F.A., Bales, R.A., Ethisham, A. et al. (2004). Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. Journal of Neurovirology, 10, 223-232.
10. Baker, S.J., & Reddy, E.P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene, 12, 1-9.
11. Bazan, N.G., Packard, M.G., Teather, L., & Allan, G. (1997). Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem Int, 30, 225-231.
12. Behan, W.M., McDonald, M., Darlington, L.G., & Stone, T.W. (1999). Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: Protection by melatonin and deprenyl. British Journal of Pharmacology, 128, 1754-1760.
13. Berger, J.R., Avison, M., Mootoor, Y., & Beach, C. (2005). Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: Preliminary observations. Journal of Neurovirology, 11, 557-562.
14. Bernasconi, S., Cinque, P., Peri, G., Sozzani, S., Crociati, A., Torri, W. et al. (1996). Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. Journal of Infectious Diseases, 174, 1098-1101.
15. Bito, H., Nakamura, M., Honda, Z., Izumi, T., Iwatsubo, T., Seyama, Y. et al. (1992). Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons. Neuron, 9, 285-294.
16. Brew, B.J. (2001a). AIDS dementia complex. In B.J. Brew (Ed.), HIV neurology (pp. 53-90). New York: Oxford University Press.
17. Brew, B.J. (2001b). Principles of HIV Neurology. In B.J. Brew (Ed.), HIV neurology (pp. 32-35). New York: Oxford University Press.
18. Brew, B.J., Bhalla, R.B., Paul, M., Gallardo, H., McArthur, J.C., Schwartz, M.K. et al. (1990). Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Annals of Neurology, 28, 556-560.
19. Brew, B.J., Bhalla, R.B., Paul, M., Sidtis, J.J., Keilp, J.J., Sadler, A.E. et al. (1992). Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment. AIDS, 6, 461-465.
20. Brew, B.J., Dunbar, N., Pemberton, L., & Kaldor, J. (1996). Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. Journal of Infectious Diseases, 174, 294-298.
21. Brew, B.J., Pemberton, L., Blennow, K., Wallin, A., & Hagberg, L. (2005). CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology, 65, 1490-1492.
22. Brew, B.J., Pemberton, L., Cunningham, P., & Law, M.G. (1997). Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. Journal of Infectious Diseases, 175, 963-966.
23. Calvo, M.E., Arranz, G.F., Sánchez-Portocarrero, J., Roca, A.V., Puente, M., Elias, A.A. et al. (1995). [Alpha tumor necrosis factor in central nervous system disease associated with HIV infection.]. An Med Interna, 12, 263-266.
24. Campbell, I.L., Krucker, T., Steffensen, S., Akwa, Y., Powell, H.C., Lane, T. et al. (1999). Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Research, 835, 46-61.
25. Cauwels, A., Frei, K., Sansano, S., Fearns, C., Ulevitch, R., Zimmerli, W. et al. (1999). The origin and function of soluble CD14 in experimental bacterial meningitis. Journal of Immunology, 162, 4762-4772.
26. Chawla-Sarkar, M., Lindner, D.J., Liu, Y.F., Williams, B.R., Sen, G.C., Silverman, R.H. et al. (2003). Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis. Apoptosis, 8, 237-249.
27. Cherner, M., Letendre, S., Heaton, R.K., Durelle, J., Marquie-Beck, J., Gragg, B. et al. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64, 1343-1347.
28. Cinque, P., Bestetti, A., Marenzi, R., Sala, S., Gisslen, M., Hagberg, L. et al. (2005). Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. Journal of Neuroimmunology, 168, 154-163.
29. Cinque, P., Nebuloni, M., Santovito, M.L., Price, R.W., Gisslen, M., Hagberg, L. et al. (2004). The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Annals of Neurology, 55, 687-694.
30. Cinque, P., Vago, L., Mengozzi, M., Torri, V., Ceresa, D., Vicenzi, E. et al. (1998). Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS, 12, 1327-1332.
31. Conant, K., Garzino-Demo, A., Nath, A., McArthur, J.C., Halliday, W., Power, C. et al. (1998). Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proceedings of the National Academy of Science of the USA, 95, 3117-3121.
32. Conant, K., McArthur, J.C., Griffin, D.E., Sjulson, L., Wahl, L.M., & Irani, D.N. (1999). Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Annals of Neurology, 46, 391-398.
33. Cosman, D. (1996). Hematopoietic cell growth factors and their receptors. In A.D. Whetten & J. Gordon (Eds.), Blood cell biochemistry, Vol 7. New York: Plenum Press.
34. Cysique, L.A., Maruff, P., & Brew, B.J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66, 1447-1450.
35. Dore, G.J., McDonald, A., Li, Y., Kaldor, J.M., & Brew, B.J. (2003). Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 17, 1539-1545.
36. Ellis, R.J., Gamst, A.C., Capparelli, E., Spector, S.A., Hsia, K., Wolfson, T. et al. (2000). Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology, 54, 927-936.
37. Ellis, R.J., Hsia, K., Spector, S.A., Nelson, J.A., Heaton, R.K., Wallace, M.R. et al. (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Annals of Neurology, 42, 679-688.
38. Ellis, R.J., Moore, D.J., Childers, M.E., Letendre, S., McCutchan, J.A., Wolfson, T. et al. (2002). Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol, 59, 923-928.
39. Elovaara, I., Iivanainen, M., Valle, S.L., Suni, J., Tervo, T., & Lahdevirta, J. (1987). CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. Journal of Neurological Science, 78, 331-342.
40. Enting, R.H., Foudraine, N.A., Lange, J.M., Jurriaans, S., van der Poll, T., Weverling, G.J. et al. (2000). Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine. Journal of Neuroimmunology, 102, 216-221.
41. Epstein, L.G., & Gelbard, H.A. (1999). HIV-1-induced neuronal injury in the developing brain. Journal of Leukoc Biol, 65, 453-457.
42. Erichsen, D., Lopez, A.L., Peng, H., Niemann, D., Williams, C., Bauer, M. et al. (2003). Neuronal injury regulates fractalkine: Relevance for HIV-1 associated dementia. Journal of Neuroimmunology, 138, 144-155.
43. Franciotta, D.M., Melzi d'Eril, G.L., Bono, G., Brustia, R., Ruberto, G., & Pagani, I. (1992). Tumor necrosis factor alpha levels in serum and cerebrospinal fluid of patients with AIDS. Funct Neurol, 7, 35-38.
44. Franconi, F., Miceli, M., De Montis, M.G., Crisafi, E.L., Bennardini, F., & Tagliamonte, A. (1996). NMDA receptors play an anti-aggregating role in human platelets. Thromb Haemost, 76, 84-87.
45. Fuchs, D., Forsman, A., Hagberg, L., Larsson, M., Norkrans, G., Reibnegger, G. et al. (1990). Immune activation and decreased tryptophan in patients with HIV-1 infection. Journal of Interferon Research, 10, 599-603.
46. Gallo, P., Frei, K., Rordorf, C., Lazdins, J., Tavolato, B., & Fontana, A. (1989a). Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid. Journal of Neuroimmunology, 23, 109-116.
47. Gallo, P., Laverda, A.M., De Rossi, A., Pagni, S., Del, Mistro, A., Cogo, P. et al. (1991). Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr Scand, 80, 659-666.
48. Gallo, P., Piccinno, M.G., Pagni, S., Argentiero, V., Giometto, B., Bozza, F. et al. (1989b). Immune activation in multiple sclerosis: Study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid. Journal of Neurological Science, 92, 9-15.
49. Gallo, P., Sivieri, S., Rinaldi, L., Yan, X.B., Lolli, F., De Rossi, A. et al. (1994). Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. Journal of Neurological Science, 126, 49-53.
50. Gelbard, H.A., Nottet, H.S., Swindells, S., Jett, M., Dzenko, K.A., Genis, P. et al. (1994). Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. Journal of Virology, 68, 4628-4635.
51. Gendelman, H.E., Zheng, J., Coulter, C.L., Ghorpade, A., Che, M., Thylin, M. et al. (1998). Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. Journal of Infectious Diseases, 178, 1000-1007.
52. Giovannoni, G., Heales, S.J., Silver, N.C., O'Riordan, J., Miller, R.F., Land, J.M. et al. (1997). Raised serum nitrate and nitrite levels in patients with multiple sclerosis. Journal of Neurological Science, 145, 77-81.
53. Giovannoni, G., Miller, R.F., Heales, S.J., Land, J.M., Harrison, M.J., & Thompson, E.J. (1998). Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: A correlation with blood-brain-barrier dysfunction. Journal of Neurological Science, 156, 53-58.
54. Gisolf, E.H., van Praag, R.M., Jurriaans, S., Portegies, P., Goudsmit, J., Danner, S.A. et al. (2000). Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 25, 426-433.
55. Gisslen, M., Hagberg, L., Rosengren, L., Brew, B.J., Cinque, P., Spudich, S. et al. (2007). Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacology, 2(1), 112-119.
56. Gisslen, M., Rosengren, L., Hagberg, L., Deeks, S.G., & Price, R.W. (2005). Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Research Therapy, 2, 6.
57. Glass, J.D., Fedor, H., Wesselingh, S.L., & McArthur, J.C. (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia. Annals of Neurology, 38, 755-762.
58. Gonzalez, E., Rovin, B.H., Sen, L., Cooke, G., Dhanda, R., Mummidi, S. et al. (2002). HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proceedings of the National Academy of Science of the USA, 99, 13795-13800.
59. Griffin, D.E., McArthur, J.C., & Cornblath, D.R. (1990). Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. Journal of Neuroimmunology, 28, 97-109.
60. Griffin, D.E., McArthur, J.C., & Cornblath, D.R. (1991). Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology, 41, 69-74.
61. Griffin, D.E., Wesselingh, S.L., & McArthur, J.C. (1994). Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Annals of Neurology, 35, 592-597.
62. Gruss, H.J., & Dower, S.K. (1995). Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404.
63. Hall, C.D., Snyder, C.R., Robertson, K.R., Messenheimer, J.A., Wilkins, J.W., Robertson, W.T. et al. (1992). Cerebrospinal fluid analysis in human immunodeficiency virus infection. Ann Clin Lab Sci, 22, 139-143.
64. Hamerlinck, F.F. (1999). Neopterin: A review. Exp Dermatol, 8, 167-176.
65. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S. et al. (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 385, 645-649.
66. Heidenreich, F., Arendt, G., Jander, S., Jablonowski, H., & Stoll, G. (1994). Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases. Journal of Neuroimmunology, 52, 117-126.
67. Hesselgesser, J., & Horuk, R. (1999). Chemokine and chemokine receptor expression in the central nervous system. Journal of Neurovirology, 5, 13-26.
68. Heyes, M.P., Brew, B., Martin, A., Markey, S.P., Price, R.W., Bhalla, R.B. et al. (1991). Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol, 294, 687-690.
69. Hu, J., Ferreira, A., & Van Eldik, L.J. (1997). S100beta induces neuronal cell death through nitric oxide release from astrocytes. Journal of Neurochemistry, 69, 2294-2301.
70. Huang, S.H., & Jong, A.Y. (2001). Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier. Cell Microbiology, 3, 277-287.
71. Johnson, M.D., Kim, P., Tourtellotte, W., & Federspiel, C.F. (2004). Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection. Journal of Neuro AIDS, 2, 33-43.
72. Kelder, W., McArthur, J.C., Nance-Sproson, T., McClernon, D., & Griffin, D.E. (1998). Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Annals of Neurology, 44, 831-835.
73. Kolb, S.A., Sporer, B., Lahrtz, F., Koedel, U., Pfister, H.W., & Fontana, A. (1999). Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. Journal of Neuroimmunology, 93, 172-181.
74. Krivine, A., Force, G., Servan, J., Cabee, A., Rozenberg, F., Dighiero, L. et al. (1999). Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: Insights into the pathogenesis of AIDS Dementia Complex. Journal of Neurovirology, 5, 500-506.
75. Kusdra, L., McGuire, D., & Pulliam, L. (2002). Changes in monocyte/macrophage neurotoxicity in the era of HAART: Implications for HIV-associated dementia. AIDS, 16, 31-38.
76. Lafeuillade, A., Poggi, C., Pellegrino, P., Corti, K., Profizi, N., & Sayada, C. (1996). HIV-1 replication in the plasma and cerebrospinal fluid. Infection, 24, 367-371.
77. Landmann, R., Muller, B., & Zimmerli, W. (2000). CD14, new aspects of ligand and signal diversity. Microbes Infect, 2, 295-304.
78. Laverda, A.M., Gallo, P., De Rossi, A., Sivieri, S., Cogo, P., Pagliaro, A. et al. (1994). Cerebrospinal fluid analysis in HIV-1-infected children: Immunological and virological findings before and after AZT therapy. Acta Paediatr, 83, 1038-1042.
79. Letendre, S., Marquie-Beck, J., Capparelli, E., Best, B., Clifford, D., Collier, A.C., et al., for the CHARTER Group. (In press). Validation of the CNS penetration-effectiveness rank for qualifying antiretroviral penetration into the central nervous system. Archives of Neurology.
80. Letendre, S., Buzzell, M., Marquie-Beck, J., Cherner, M., Ances, B. & Ellis, R.J., ATH Group. (2006). The effects of antiretroviral use on cerebrospinal fluid biomarkers and neuropsychological performance. In 13th Conference on Retroviruses and Opportunistic Infections: Denver, CO. Available at: www.retroconference.org/2008/.
81. Letendre, S., Zheng, J., Yiannoutsos, C., Lopez, A., Ellis, R., Marquie-Beck, J., et al. (2004). Chemokines correlate with cerebral metabolites on magnetic resonance spectroscopy: A sub-study of ACTG 301 and 700. In 11th Conference on Retroviruses and Opportunistic Infections: San Francisco, CA. Available at: www.retroconference.org/2008/.
82. Letendre, S.L., Cherner, M., Ellis, R.J., Marquie-Beck, J., Gragg, B., Marcotte, T. et al. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS, 19(Suppl 3), S72-78.
83. Letendre, S.L., Lanier, E.R., & McCutchan, J.A. (1999). Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. Journal of Infectious Diseases, 180, 310-319.
84. Lien, E., Aukrust, P., Sundan, A., Muller, F., Froland, S.S., & Espevik, T. (1998). Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events. Blood, 92, 2084-2092.
85. Liuzzi, G.M., Mastroianni, C.M., Santacroce, M.P., Fanelli, M., D'Agostino, C., Vullo, V. et al. (2000). Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. Journal of Neurovirology, 6, 156-163.
86. Lotz, M., Terkeltaub, R., & Villiger, P.M. (1992). Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. Journal of Immunology, 148, 466-473.
87. Luo, X., Carlson, K.A., Wojna, V., Mayo, R., Biskup, T.M., Stoner, J. et al. (2003). Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology, 60, 1931-1937.
88. Marshall, D.W., Brey, R.L., Butzin, C.A., Lucey, D.R., Abbadessa, S.M., & Boswell, R.N. (1991). CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected US Air Force personnel. Journal of Acquired Immune Deficiency Syndrome, 4, 777-781.
89. Marshall, D.W., Brey, R.L., Cahill, W.T., Houk, R.W., Zajac, R.A., & Boswell, R.N. (1988). Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol, 45, 954-958.
90. Martin, A., Heyes, M.P., Salazar, A.M., Kampen, D.L., Williams, J., Law, W.A. et al. (1992). Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. Journal of Neuropsychiatry Clin Neurosci, 4, 270-279.
91. Mastroianni, C.M., Paoletti, F., Massetti, A.P., Falciano, M., & Vullo, V. (1990). Elevated levels of tumor necrosis factor (TNF) in the cerebrospinal fluid from patients with HIV-associated neurological disorders. Acta Neurologica (Napoli), 12, 66-67.
92. Mastroianni, C.M., Paoletti, F., Valenti, C., Vullo, V., Jirillo, E., & Delia, S. (1992). Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection. Journal of Neurol Neurosurg Psychiatry, 55, 219-221.
93. McArthur, J.C., McClernon, D.R., Cronin, M.F., Nance-Sproson, T.E., Saah, A.J., St Clair, M. et al. (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology, 42, 689-698.
94. McArthur, J.C., Nance-Sproson, T.E., Griffin, D.E., Hoover, D., Selnes, O.A., Miller, E.N. et al. (1992). The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology, 42, 1707-1712.
95. Milstien, S., Sakai, N., Brew, B.J., Krieger, C., Vickers, J.H., Saito, K. et al. (1994). Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. Journal of Neurochemistry, 63, 1178-1180.
96. Monteiro de Almeida, S., Letendre, S., Zimmerman, J., Lazzaretto, D., McCutchan, A., & Ellis, R. (2005). Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Journal of Neuroimmunology, 169, 144-152.
97. Neuenburg, J.K., Furlan, S., Bacchetti, P., Price, R.W., & Grant, R.M. (2005). Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS, 19, 1351-1359.
98. Nockher, W.A., Bergmann, L., & Scherberich, J.E. (1994). Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol, 98, 369-374.
99. Norgren, N., Rosengren, L., & Stigbrand, T. (2003). Elevated neurofilament levels in neurological diseases. Brain Research, 987, 25-31.
100. Oppenheim, J.J., & Ruscetti, F.W. (2001). Cytokines. In T.G. Parslow, D.P. Stites, A.I. Terr & J.B. Imboden (Eds.), Medical immunology. New York: Lange Medical Books/McGraw-Hill Medical Publishing.
101. Pemberton, L.A., & Brew, B.J. (2001). Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. Journal of Clinical Virology, 22, 249-253.
102. Perrella, O., Carreiri, P.B., Perrella, A., Sbreglia, C., Gorga, F., Guarnaccia, D. et al. (2001). Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): Possible relationship with cerebral viral load? European Cytokine Network, 12, 51-55.
103. Perrella, O., Carrieri, P.B., Guarnaccia, D., & Soscia, M. (1992). Cerebrospinal fluid cytokines in AIDS dementia complex. Journal of Neurology, 239, 387-388.
104. Petzold, A., Hinds, N., Murray, N.M., Hirsch, N.P., Grant, D., Keir, G. et al. (2006). CSF neurofilament levels: A potential prognostic marker in Guillain-Barre syndrome. Neurology, 67, 1071-1073.
105. Portegies, P., Godfried, M.H., Hintzen, R.Q., Stam, J., van der Poll, T., Bakker, M. et al. (1993). Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex. Journal of Neuroimmunology, 48, 241-247.
106. Pulliam, L., Gascon, R., Stubblebine, M., McGuire, D., & McGrath, M.S. (1997). Unique monocyte subset in patients with AIDS dementia. Lancet, 349, 692-695.
107. Re, D.B., & Przedborski, S. (2006). Fractalkine: Moving from chemotaxis to neuroprotection. Nat Neurosci, 9, 859-861.
108. Rho, M.B., Wesselingh, S., Glass, J.D., McArthur, J.C., Choi, S., Griffin, J. et al. (1995). A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav Immun, 9, 366-377.
109. Rieckmann, P., Albrecht, M., Ehrenreich, H., Weber, T., & Michel, U. (1995). Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med (Berl), 195, 17-29.
110. Rieckmann, P., Nunke, K., Burchhardt, M., Albrecht, M., Wiltfang, J., Ulrich, M. et al. (1993). Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: An indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. Journal of Neuroimmunology, 47, 133-140.
111. Riedel, D.J., Pardo, C.A., McArthur, J., & Nath, A. (2006). Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol, 2, 557-565.
112. Rosenberg, G.A. (2002). Matrix metalloproteinases in neuroinflammation. Glia, 39, 279-291.
113. Ryan, L.A., Zheng, J., Brester, M., Bohac, D., Hahn, F., Anderson, J. et al. (2001). Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. Journal Infectious Diseases, 184, 699-706.
114. Sabri, F., De Milito, A., Pirskanen, R., Elovaara, I., Hagberg, L., Cinque, P. et al. (2001). Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. Journal of Neuroimmunology, 114, 197-206.
115. Sacktor, N., Haughey, N., Cutler, R., Tamara, A., Turchan, J., Pardo, C. et al. (2004). Novel markers of oxidative stress in actively progressive HIV dementia. Journal of Neuroimmunology, 157, 176-184.
116. Sanders, V.J., Pittman, C.A., White, M.G., Wang, G., Wiley, C.A., & Achim, C.L. (1998). Chemokines and receptors in HIV encephalitis. AIDS, 12, 1021-1026.
117. Sasseville, V.G., Smith, M.M., Mackay, C.R., Pauley, D.R., Mansfield, K.G., Ringler, D.J. et al. (1996). Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. American Journal of Pathology, 149, 1459-1467.
118. Schmidtmayerova, H., Nottet, H.S., Nuovo, G., Raabe, T., Flanagan, C.R., Dubrovsky, L. et al. (1996). Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proceedings of the National Academy of Science of the USA, 93, 700-704.
119. Scorziello, A., Florio, T., Bajetto, A., Thellung, S., & Schettini, G. (1997). TGF-beta1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic death. Journal of Neuroscience Research, 49, 600-607.
120. Sevigny, J.J., Albert, S.M., McDermott, M.P., McArthur, J.C., Sacktor, N., Conant, K. et al. (2004). Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology, 63, 2084-2090.
121. Shacklett, B.L., Cox, C.A., Wilkens, D.T., Karl Karlsson, R., Nilsson, A., Nixon, D.F. et al. (2004). Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. Journal of Infectious Diseases, 189, 2202-2212.
122. Shiramizu, B., Gartner, S., Williams, A., Shikuma, C., Ratto-Kim, S., Watters, M. et al. (2005). Circulating proviral HIV DNA and HIV-associated dementia. AIDS, 19, 45-52.
123. Shiramizu, B., Lau, E., Tamamoto, A., Uniatowski, J., & Troelstrup, D. (2006). Feasibility assessment of cerebrospinal fluid from HIV-1-infected children for HIV proviral DNA and monocyte chemoattractant protein 1 alleles. Journal of Investigative Medicine, 54, 468-472.
124. Singer, E.J., Syndulko, K., Fahy-Chandon, B., Schmid, P., Conrad, A., & Tourtellotte, W.W. (1994). Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. Journal of Acquired Immune Deficiency Syndrome, 7, 265-271.
125. Sozzani, S., Introna, M., Bernasconi, S., Polentarutti, N., Cinque, P., Poli, G. et al. (1997). MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression. Journal of Leukoc Biol, 62, 30-33.
126. Sporer, B., Kastenbauer, S., Koedel, U., Arendt, G., & Pfister, H.W. (2003). Increased intrathecal release of soluble fractalkine in HIV-infected patients. AIDS Res Hum Retroviruses, 19, 111-116.
127. Sporer, B., Koedel, U., Goebel, F.D., & Pfister, H.W. (2000). Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients. AIDS Res Hum Retroviruses, 16, 221-226.
128. Sporer, B., Koedel, U., Paul, R., Eberle, J., Arendt, G., & Pfister, H.W. (2004a). Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases. Journal of Neurol Neurosurg Psychiatry, 75, 298-300.
129. Sporer, B., Missler, U., Magerkurth, O., Koedel, U., Wiesmann, M., & Pfister, H.W. (2004b). Evaluation of CSF glial fibrillary acidic protein (GFAP) as a putative marker for HIV-associated dementia. Infection, 32, 20-23.
130. Sporer, B., Paul, R., Koedel, U., Grimm, R., Wick, M., Goebel, F.D. et al. (1998). Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. Journal of Infectious Diseases, 178, 854-857.
131. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., & Schreiber, R.D. (1998). How cells respond to interferons. Annu Rev Biochem, 67, 227-264.
132. Torre, D., Zeroli, C., Ferraro, G., Speranza, F., Tambini, R., Martegani, R. et al. (1992). Cerebrospinal fluid levels of IL-6 in patients with acute infections of the central nervous system. Scandinavian Journal of Infectious Diseases, 24, 787-791.
133. Towfighi, A., Skolasky, R.L., St Hillaire, C., Conant, K., & McArthur, J.C. (2004). CSF soluble Fas correlates with the severity of HIV-associated dementia. Neurology, 62, 654-656.
134. Tozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R., Galgani, S., Corpolongo, A. et al. (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11, 265-273.
135. Tungaturthi, P.K., Sawaya, B.E., Singh, S.P., Tomkowicz, B., Ayyavoo, V., Khalili, K. et al. (2003). Role of HIV-1 Vpr in AIDS pathogenesis: Relevance and implications of intravirion, intracellular and free Vpr. Biomed Pharmacother, 57, 20-24.
136. Tyor, W.R., Glass, J.D., Griffin, J.W., Becker, P.S., McArthur, J.C., Bezman, L. et al. (1992). Cytokine expression in the brain during the acquired immunodeficiency syndrome. Annals of Neurology, 31, 349-360.
137. Valcour, V., Yee, P., Williams, A.E., Shiramizu, B., Watters, M., Selnes, O. et al. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection - The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12, 387-391.
138. Valle, M., Price, R.W., Nilsson, A., Heyes, M., & Verotta, D. (2004). CSF quinolinic acid levels are determined by local HIV infection: Cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain, 127, 1047-1060.
139. von Giesen, H.J., Jander, S., Koller, H., & Arendt, G. (2004). Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease. Journal of Neurovirology, 10, 383-386.
140. Vullo, V., Mastroianni, C.M., Lichtner, M., Mengoni, F., & Delia, S. (1995). Increased cerebrospinal fluid levels of soluble receptors for tumour necrosis factor in HIV-infected patients with neurological diseases. AIDS, 9, 1099-1100.
141. Ware, C.F., VanArsdale, S., & VanArsdale, T.L. (1996). Apoptosis mediated by the TNF-related cytokine and receptor families. Journal of Cell Biochem, 60, 47-55.
142. Weiss, J.M., Nath, A., Major, E.O., & Berman, J.W. (1999). HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. Journal of Immunology, 163, 2953-2959.
143. Wesselingh, S.L., Glass, J., McArthur, J.C., Griffin, J.W., & Griffin, D.E. (1994). Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol, 4, 199-206.
144. Westmoreland, S.V., Rottman, J.B., Williams, K.C., Lackner, A.A., & Sasseville, V.G. (1998). Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. American Journal of Pathology, 152, 659-665.
145. Wojna, V., Carlson, K.A., Luo, X., Mayo, R., Melendez, L.M., Kraiselburd, E. et al. (2004). Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: A case study. Journal of Neurovirology, 10(Suppl.1), 74-81.
146. Zoumpourlis, V., Eliopoulos, A.G., & Spandidos, D.A. (1992). Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by tumor necrosis factor. Anticancer Research, 12, 2065-2068.